This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Newsouth Innovations Pty Limited, Universitetet I Oslo, Vestlandets Innovasjonsseiskap as. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nesttun, NO (2019 - 2021)
- Bergen, NO (2017 - 2023)
Company Filing History:

Years Active: 2017-2023
Title: Ralf Kellmann: Innovator in Saxitoxin Research
Introduction
Ralf Kellmann is a notable inventor based in Nesttun, Norway. He has made significant contributions to the field of biochemistry, particularly in the study of saxitoxins. With a total of 5 patents, his work has implications for both pharmaceutical applications and environmental monitoring.
Latest Patents
Kellmann's latest patents include innovative processes for the production of neosaxitoxin and its analogues. The first patent focuses on methods to create neosaxitoxin and its variants using recombinant host cells. This invention has potential applications in developing pharmaceutical compositions. Another significant patent addresses the detection of saxitoxin-producing dinoflagellates. This invention provides methods for identifying genes that encode saxitoxin in these microorganisms, facilitating the specific detection of dinoflagellates that produce saxitoxins.
Career Highlights
Throughout his career, Ralf Kellmann has worked with various organizations, including Newsouth Innovations Pty Limited and Vestlandets Innovasjonsseiskap AS. His expertise in biochemistry and innovative approaches to research have positioned him as a key figure in his field.
Collaborations
Kellmann has collaborated with notable individuals such as Brett A. Neilan and Shauna Ann Murray. These partnerships have contributed to the advancement of research in saxitoxins and their applications.
Conclusion
Ralf Kellmann's contributions to the field of saxitoxin research highlight his innovative spirit and dedication to advancing scientific knowledge. His patents and collaborations reflect a commitment to addressing important challenges in biochemistry and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile